![The European Medicines Agency (EMA) is delivering a Product Management Service (PMS) and a Substance Management Service (SMS) to support regulatory activities in the European Union (EU) | Pharmya The European Medicines Agency (EMA) is delivering a Product Management Service (PMS) and a Substance Management Service (SMS) to support regulatory activities in the European Union (EU) | Pharmya](https://www.pharmya.com/wp-content/uploads/2023/02/Ema-logo.jpg)
The European Medicines Agency (EMA) is delivering a Product Management Service (PMS) and a Substance Management Service (SMS) to support regulatory activities in the European Union (EU) | Pharmya
![European Medicines Agency approves pembrolizumab plus axitinib for first-line treatment of advanced kidney cancer - Action Kidney Cancer European Medicines Agency approves pembrolizumab plus axitinib for first-line treatment of advanced kidney cancer - Action Kidney Cancer](https://actionkidneycancer.org/wp-content/uploads/2021/02/EMA.jpg)
European Medicines Agency approves pembrolizumab plus axitinib for first-line treatment of advanced kidney cancer - Action Kidney Cancer
![European Medicines Agency (EMA) launches pilot project on drug repurposing – EJP RD – European Joint Programme on Rare Diseases European Medicines Agency (EMA) launches pilot project on drug repurposing – EJP RD – European Joint Programme on Rare Diseases](https://www.ejprarediseases.org/wp-content/uploads/2021/10/EMApilotproject-e1635930571908-1200x600.png)
European Medicines Agency (EMA) launches pilot project on drug repurposing – EJP RD – European Joint Programme on Rare Diseases
![European Medicines Agency (EMA) | CDE Almería - Centro de Documentación Europea - Universidad de Almería European Medicines Agency (EMA) | CDE Almería - Centro de Documentación Europea - Universidad de Almería](https://www.cde.ual.es/wp-content/uploads/2022/07/ema-logo-1024x455-1.webp)